IPMC 2025 _ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2025) scheduled during March 13-15, 2025 in Rome, Italy has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at precision-medicine@magnusconference.com or call + 1 (702) 988 2320.
3rd Edition of International Precision Medicine Conference
March 13-15, 2025
Precision Medicine in Cancer diagnosis and treatment
Precision medicine, often known as personalized medicine, is becoming an important aspect of current cancer treatment. It involves adapting treatment to mutations detected in the patient's tumor rather than tailoring treatment to a person's individual genome sequence. Precision medicine in cancer entails analyzing DNA from tumors to find mutations or other genetic abnormalities that cause the cancer. Healthcare professionals may therefore be able to choose a treatment for a specific patient's cancer that best fits, or targets, the tumor DNA alterations. Such treatments are becoming more prominent. Precision medicine already has a significant impact on cancer diagnosis and therapy, and it will become even more so in the future.
- Tumor Sequencing
- Drugs for inhibiting driver mutations
- Progression of precision medicine
Alain Chapel
Institute Of Radiological Protection And Nuclear Safety, France
Sergio Marchini
Humanitas Research Hospital, Italy
Michael Thompson
University of Toronto, CanadaSubmit your abstract Today
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to secure the human healthcare, wellness and biosafety through the view of public health, network-driven healthcare services and lifestyle management
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Potential serum biomarkers for early detection of diabetic nephropathy
Tarek Kamal Motawi , Cairo University, Egypt
Title : Personalized & Precision Medicine (PPM) as a Unique Avenue to have the Healthcare Model Renewed to Secure the National Biosafety: Through The View of Obesity Nutrition to Reach the Personalized Diet Harmony and Lifestyle Wellness
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Personalized and Precision Medicine (PPM) thought The View of Reproductive Healthcare and Natural Family Planning: An Option for clinicians and caregivers realize the potential of genomics-informed care to secure the Individualized Human Biosafety
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : 3D Bioprinting complicated large organs with a vascular system
Vyacheslav R Shulunov, Russian Academy of Science, Russian Federation
Title : Persian medicine, medicine based on temperament
Mehdi Zarvandi, Golestan University of Medical Sciences, Iran (Islamic Republic of)